Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4.

Chen J, Hartono JR, John R, Bennett M, Zhou XJ, Wang Y, Wu Q, Winterberg PD, Nagami GT, Lu CY.

Kidney Int. 2011 Sep;80(5):504-15. doi: 10.1038/ki.2011.140. Epub 2011 Jun 1.

2.

Dangers within: DAMP responses to damage and cell death in kidney disease.

Rosin DL, Okusa MD.

J Am Soc Nephrol. 2011 Mar;22(3):416-25. doi: 10.1681/ASN.2010040430. Epub 2011 Feb 18. Review.

3.

Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies.

Barochia A, Solomon S, Cui X, Natanson C, Eichacker PQ.

Expert Opin Drug Metab Toxicol. 2011 Apr;7(4):479-94. doi: 10.1517/17425255.2011.558190. Epub 2011 Feb 17. Review.

4.

HMGB1 is a therapeutic target for sterile inflammation and infection.

Andersson U, Tracey KJ.

Annu Rev Immunol. 2011;29:139-62. doi: 10.1146/annurev-immunol-030409-101323. Review.

5.

Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury.

Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi-Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA.

Am J Physiol Renal Physiol. 2011 Mar;300(3):F721-33. doi: 10.1152/ajprenal.00546.2010. Epub 2010 Dec 1.

6.

Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice.

Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC.

Br J Pharmacol. 2011 Apr;162(7):1498-508. doi: 10.1111/j.1476-5381.2010.01126.x.

7.

An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury.

Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia Jda S, Ulevitch RJ, Hoffman HM, McKay DB.

J Immunol. 2010 Nov 15;185(10):6277-85. doi: 10.4049/jimmunol.1002330. Epub 2010 Oct 20. Erratum in: J Immunol. 2011 Feb 1;186(3):1880.

8.

Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury.

Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, Wu QQ, Hartono JR, Winterberg PD, Lu CY.

Kidney Int. 2011 Feb;79(3):288-99. doi: 10.1038/ki.2010.381. Epub 2010 Oct 6.

9.

HMGB1 contributes to kidney ischemia reperfusion injury.

Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ.

J Am Soc Nephrol. 2010 Nov;21(11):1878-90. doi: 10.1681/ASN.2009101048. Epub 2010 Sep 16.

10.

Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury.

Li J, Gong Q, Zhong S, Wang L, Guo H, Xiang Y, Ichim TE, Wang CY, Chen S, Gong F, Chen G.

Nephrol Dial Transplant. 2011 Feb;26(2):469-78. doi: 10.1093/ndt/gfq466. Epub 2010 Aug 2.

PMID:
20679140
11.

The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.

Renner B, Coleman K, Goldberg R, Amura C, Holland-Neidermyer A, Pierce K, Orth HN, Molina H, Ferreira VP, Cortes C, Pangburn MK, Holers VM, Thurman JM.

J Immunol. 2010 Sep 1;185(5):3086-94. doi: 10.4049/jimmunol.1000111. Epub 2010 Jul 30.

12.

Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemia-reperfusion injury.

Liu M, Gu M, Xu D, Lv Q, Zhang W, Wu Y.

Transplant Proc. 2010 Jun;42(5):1539-44. doi: 10.1016/j.transproceed.2010.03.133.

PMID:
20620471
13.

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.

Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, Tracey KJ.

Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11942-7. doi: 10.1073/pnas.1003893107. Epub 2010 Jun 14.

14.

The sterile inflammatory response.

Rock KL, Latz E, Ontiveros F, Kono H.

Annu Rev Immunol. 2010;28:321-42. doi: 10.1146/annurev-immunol-030409-101311. Review.

16.

Acute kidney injury: a springboard for progression in chronic kidney disease.

Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK.

Am J Physiol Renal Physiol. 2010 May;298(5):F1078-94. doi: 10.1152/ajprenal.00017.2010. Epub 2010 Mar 3. Review.

17.

Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury.

Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C, Roos M, Kirschning C, Heemann U, Lutz J.

Pediatr Nephrol. 2010 May;25(5):853-60. doi: 10.1007/s00467-009-1422-4. Epub 2010 Feb 4.

PMID:
20130923
18.

Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury.

Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva Correia J, Ulevitch RJ, McKay DB.

J Immunol. 2010 Mar 1;184(5):2297-304. doi: 10.4049/jimmunol.0903065. Epub 2010 Feb 1.

19.

TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice.

González-Navajas JM, Fine S, Law J, Datta SK, Nguyen KP, Yu M, Corr M, Katakura K, Eckman L, Lee J, Raz E.

J Clin Invest. 2010 Feb;120(2):570-81. doi: 10.1172/JCI40055. Epub 2010 Jan 4.

20.

IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury.

Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD.

J Clin Invest. 2010 Jan;120(1):331-42. doi: 10.1172/JCI38702. Epub 2009 Dec 14.

Supplemental Content

Support Center